AGP Picks
View all

Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on October 19, 2026

The Steelhouse Marks Nearly One Year of Expanding Opportunity for Greensboro Entrepreneurs
SONYA DAKAR's Zit Buster Ranked No. 1 in Pravi Celer's 2026 Best Spot Treatments for Pimples Guide
Remote Heart Monitoring at KFSH Reduces Heart Failure Admissions by 46%
KFSH Cuts Emergency Department Boarding Time by 75% Through AI-Enabled Patient Flow System
XBiotech gibt positive endgültige Wirksamkeitsergebnisse der Phase-II-Studie „TASKIN“ bekannt, einer von Forschern initiierten Studie zur Behandlung von refraktärem metastasiertem Kolorektalkarzinom
XBiotech annonce des résultats d’efficacité finaux positifs de phase II pour l’essai TASKIN commandité par un chercheur dans le cancer colorectal métastatique réfractaire
Pharmacore secures funding to improve medication regimen reviews in long-term care
Conavi Medical Announces New Grants of Stock Options
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026
SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026
Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026
Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
CRISPR Therapeutics Announces Chief Financial Officer Transition
Integra Announces Completion of Refinancing Transactions
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Latin America Health Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.